Bill · H.R. 4639· House(119-HR-4639)
Infertility Treatment Affordability Act of 2025
- Introduced
- 7/23/2025
- Last activity
- 7/23/2025 — Referred to the House Committee on Ways and Means.
- Sponsored by
- Mike Carey
- Cosponsors
- - 1 - 3
- Introduced
- In Committee
What this bill would do
The Infertility Treatment Affordability Act of 2025 seeks to amend the Internal Revenue Code to provide an income tax credit for infertility treatment costs. This credit allows eligible individuals to claim an amount equal to 50 percent of qualified infertility treatment expenses. The bill establishes specific dollar limitations, income limitations, and rules regarding refundable portions of the credit. It also defines qualified expenses, including fertility preservation procedures in certain medical contexts. The legislation includes provisions for carrying forward unused credits to succeeding taxable years. These changes are intended to take effect for taxable years beginning after December 31, 2024.
Yes· 3 of 7
Would women be better off under this?+6
The bill provides financial support for infertility treatments and fertility preservation often relevant to women's health.
Does this make health care easier to get in general?+6
The bill reduces the financial burden of infertility treatments and fertility preservation.
Would people in their twenties and thirties be better off under this?+5
The credit provides financial assistance for fertility treatments which are often sought by younger individuals.
The opposite
Does this reduce what the federal government spends?-2
The bill creates a new tax credit which reduces federal tax revenue.
Who it would affect, and how
Potential Positive Impacts for People
-
Tax Credit for Treatment Costs: Eligible individuals can receive a credit equal to 50 percent of qualified infertility treatment expenses paid or incurred during the taxable year (Section 2. (a)).
-
Support for Fertility Preservation: The bill allows for expenses related to fertility preservation procedures conducted prior to medical procedures that may cause involuntary infertility or sterilization to be treated as qualified expenses (Section 2. (d)(2)(A)).
-
Refundable Credit Component: Up to $5,000 of the credit can be treated as a refundable credit (Section 2. (b)(3)(A)).
-
Carryforward of Credits: If the credit exceeds certain limitations, the excess can be carried forward to succeeding taxable years for up to five years (Section 2. (c)(1)-(2)).
Potential Negative Impacts for People
-
Income Limitations: The amount of the credit may be reduced based on the taxpayer's adjusted gross income (Section 2. (b)(2)(A)).
-
Dollar Limitations: The credit is subject to a specific dollar limitation for any taxable year (Section 2. (b)(1)).
-
Exclusions for Certain Procedures: Expenses for fertility preservation procedures designed specifically to result in infertility or sterilization are not considered qualified expenses (Section 2. (d)(2)(B)).
-
Denial of Credit if Reimbursed: The credit cannot be claimed for expenses that are reimbursed by insurance policies or through Federal, State, or local programs (Section 2. (b)(4)(B)-(C)).
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Demographic And Interest Groups
- Good For Women+6Good For Low Income Households+5Good For Middle Class Households+5Good For Young Adults+5
- Healthcare
- Improves Healthcare Access+6
- Economy And Finance
- Reduces Middle Class Taxes+5Reduces Government Spending-2
- Social Issues And Justice
- Improves Poverty Reduction+2
- 10/31/2025
- 1 Cosponsor added.
- 9/15/2025
- 1 Cosponsor added.
- 7/23/2025
- Referred to the House Committee on Ways and Means.
- 2 Cosponsors added.
- Introduced in House
Laura GillenDemocrat · New York
Greg LandsmanDemocrat · Ohio
Max MillerRepublican · Ohio
Eugene VindmanDemocrat · Virginia